Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01663727 |
|---|---|
| Brief Title: | Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer |
| First Submitted : | August 9, 2012 |
| First Submitted that Met QC Criteria : | August 9, 2012 |
| First Posted : | August 13, 2012 (Estimate) |
| Results First Submitted : | January 12, 2016 |
| Results First Submitted that Met QC Criteria : | January 12, 2016 |
| Results First Posted : | February 10, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 7, 2019 |
| Last Update Posted : | January 22, 2019 |